The impact of cardiogenic shock and out-of-hospital cardiac arrest on the outcome of acute myocardial infarction: a national-level analysis

. 2025 Jun 13 ; () : . [epub] 20250613

Status Publisher Jazyk angličtina Země Itálie Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid40514615

Grantová podpora
NV19-02-00086 Ministerstvo Zdravotnictví Ceské Republiky
LX22NPO5104 Univerzita Karlova v Praze

Odkazy

PubMed 40514615
DOI 10.1007/s11739-025-03984-6
PII: 10.1007/s11739-025-03984-6
Knihovny.cz E-zdroje

Cardiogenic shock (CS) and out-of-hospital cardiac arrest (OHCA) are events with profound implications for patient outcomes. We aim to analyze the predictors of CS and OHCA in patients with acute myocardial infarction and their effects on mortality. The analysis is based on data from a national registry between 2016 and 2020. A total of 23,703 patients with ST-elevation myocardial infarction (STEMI) were analyzed: (A) patients without CS and OHCA (19,590), (B) after OHCA (2,262), (C) with CS (713), and (D) after OHCA with CS (1,138). Patients after OHCA without CS had the lowest mean age [62.0 (± 12.6) years], while patients with CS without OHCA were the oldest [68.8 (± 11.8) years] and had the highest proportions of comorbidities. CS was a predictor of 30-day and 1-year mortality, with odds ratios [OR; 95% confidence intervals (CI)] of 5.52 (4.51; 6.75) and 4.66 (3.87; 5.61) for patients after OHCA, and OR (95% CI) 9.28 (7.56; 11.38) and 7.33 (6.04; 8.89) for those without OHCA. For overall survival up to 30 days and in comparison to patients without CS and OHCA, the hazard ratios (95% CI) was 2.77 (2.40; 3.20) for patients with OHCA only, 14.36 (12.57; 16.40) for patients with CS only, and 16.96 (15.19; 18.92) for patients with both CS and OHCA. OHCA altered the 30-day mortality risk after STEMI for both patients with and without CS. CS is a predictor of both 30-day and 1-year mortality in patients with STEMI, irrespective of OHCA status.

1st Department of Internal Medicine and Cardioangiology International Clinical Research Center Faculty of Medicine St Anne's University Hospital Masaryk University Brno Czech Republic

Cardiocenter Liberec Regional Hospital Liberec Czech Republic

Cardiocentre 3rd Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady Srobarova 50 100 34 Prague Czech Republic

Department of Cardiology Faculty of Medicine University Hospital Charles University Pilsen Czech Republic

Department of Cardiology Hospital of Pardubice Pardubice Czech Republic

Department of Cardiology Krajska Zdravotni A S Masaryk Hospital Jan Evangelista Purkyne University Usti nad Labem Czech Republic

Department of Cardiology Nemocnice Agel Trinec Podlesi Trinec Czech Republic

Department of Cardiology T Bata Regional Hospital Zlin Czech Republic

Department of Cardiovascular Surgery University Hospital Ostrava Czech Republic

Department of Internal Medicine 1 and Cardiology Faculty of Medicine and Dentistry University Hospital Palacky University Olomouc Czech Republic

Department of Internal Medicine and Cardiology University Hospital Faculty of Medicine of Masaryk University Brno Czech Republic

Departmet of Cardiovascular Medicine University Hospital Hradec Kralove Czech Republic

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

Institute of Clinical and Experimental Medicine Cardiology Prague Czech Republic

Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic

Regional Hospital Ceske Budejovice Czech Republic

Zobrazit více v PubMed

Tsao CW, Aday AW, Almarzooq ZI et al (2023) Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. https://doi.org/10.1161/CIR.0000000000001123 PubMed DOI PMC

Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S (2019) Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J 40(32):2671–2683. https://doi.org/10.1093/eurheartj/ehz363 PubMed DOI

Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV (2021) Cardiogenic shock after acute myocardial infarction. JAMA 326(18):1840. https://doi.org/10.1001/jama.2021.18323 PubMed DOI PMC

Sterling LH, Fernando SM, Talarico R et al (2023) Long-term outcomes of cardiogenic shock complicating myocardial infarction. J Am Coll Cardiol 82(10):985–995. https://doi.org/10.1016/j.jacc.2023.06.026 PubMed DOI

Kolte D, Khera S, Aronow WS et al (2014) Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. https://doi.org/10.1161/JAHA.113.000590 PubMed DOI PMC

Davodian LW, Larsen JKP, Povlsen AL et al (2022) Timing and causes of death in acute myocardial infarction complicated by cardiogenic shock (from the RETROSHOCK Cohort). Am J Cardiol 171:15–22. https://doi.org/10.1016/j.amjcard.2022.01.050 PubMed DOI

Helgestad OKL, Josiassen J, Hassager C et al (2019) Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study. Eur J Heart Fail 21(11):1370–1378. https://doi.org/10.1002/ejhf.1566 PubMed DOI

Thiele H, Akin I, Sandri M et al (2018) One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med 379(18):1699–1710. https://doi.org/10.1056/NEJMoa1808788 PubMed DOI

Thiele H, Zeymer U, Neumann FJ et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296. https://doi.org/10.1056/NEJMoa1208410 PubMed DOI

Thiele H, Akin I, Sandri M et al (2017) PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 377(25):2419–2432. https://doi.org/10.1056/NEJMoa1710261 PubMed DOI

Lauridsen MD, Rørth R, Lindholm MG et al (2020) Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction–related cardiogenic shock from 2005 to 2017: a nationwide cohort study. Am Heart J 229:127–137. https://doi.org/10.1016/j.ahj.2020.08.012 PubMed DOI

Thiele H, Zeymer U, Akin I et al (2023) Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med 389(14):1286–1297. https://doi.org/10.1056/NEJMoa2307227 PubMed DOI

Sonoda T, Wada H, Ogita M et al (2022) Clinical features and predictors of outcome in patients with acute myocardial infarction complicated by out-of-hospital cardiac arrest. BMC Cardiovasc Disord 22(1):185. https://doi.org/10.1186/s12872-022-02628-3 PubMed DOI PMC

Kosugi S, Shinouchi K, Ueda Y et al (2020) Clinical and angiographic features of patients with out-of-hospital cardiac arrest and acute myocardial infarction. J Am Coll Cardiol 76(17):1934–1943. https://doi.org/10.1016/j.jacc.2020.08.057 PubMed DOI

Kvakkestad KM, Sandvik L, Andersen GØ, Sunde K, Halvorsen S (2018) Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: a prospective cohort study. Resuscitation 122:41–47. https://doi.org/10.1016/j.resuscitation.2017.11.047 PubMed DOI

Jánosi A, Ferenci T, Tomcsányi J, Andréka P (2021) Out-of-hospital cardiac arrest in patients treated for ST-elevation acute myocardial infarction: incidence, clinical features, and prognosis based on population-level data from Hungary. Resusc Plus 6:100113. https://doi.org/10.1016/j.resplu.2021.100113 PubMed DOI PMC

Zheng WC, Dinh D, Noaman S et al (2023) Effect of concomitant cardiac arrest on outcomes in patients with acute coronary syndrome-related cardiogenic shock. Am J Cardiol 204:104–114. https://doi.org/10.1016/j.amjcard.2023.06.123 PubMed DOI

Samsky M, Krucoff M, Althouse AD et al (2020) Clinical and regulatory landscape for cardiogenic shock: a report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. Am Heart J 219:1–8. https://doi.org/10.1016/j.ahj.2019.10.006 PubMed DOI

Fuernau G, Poenisch C, Eitel I et al (2015) Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Int J Cardiol 191:159–166. https://doi.org/10.1016/j.ijcard.2015.04.242 PubMed DOI

Dziewierz A, Siudak Z, Rakowski T, Dubiel JS, Dudek D (2010) Predictors and in-hospital outcomes of cardiogenic shock on admission in patients with acute coronary syndromes admitted to hospitals without on-site invasive facilities. Acute Card Care 12(1):3–9. https://doi.org/10.3109/17482941003637106 PubMed DOI

Bataille Y, Déry JP, Larose É et al (2012) Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction. Am Heart J 164(4):509–515. https://doi.org/10.1016/j.ahj.2012.07.008 PubMed DOI

Tyler JM, Brown C, Jentzer JC et al (2022) Variability in reporting of key outcome predictors in acute myocardial infarction cardiogenic shock trials. Catheter Cardiovasc Interv 99(1):19–26. https://doi.org/10.1002/ccd.29710 PubMed DOI

Belohlavek J, Smalcova J, Rob D et al (2022) Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest. JAMA 327(8):737. https://doi.org/10.1001/jama.2022.1025 PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...